Objective. Fos protein expression in catecholamine-synthesizing neurons of the substantia nigra (SN) pars compacta (SNC, A8), pars reticulata (SNR, A9), and pars lateralis (SNL), the ventral tegmental area (VTA, A10), the locus coeruleus (LC, A6) and subcoeruleus (sLC), the ventrolateral pons (PON-A5), the nucleus of the solitary tract (NTS-A2), the area postrema (AP), and the ventrolateral medulla (VLM-A1) was quantitatively evaluated aft er a single administration of asenapine (ASE) (designated for schizophrenia treatment) in male Wistar rats preconditioned with a chronic unpredictable variable mild stress (CMS) for 21 days. Th e aim of the present study was to reveal whether a single ASE treatment may 1) activate Fos expression in the brain areas selected; 2) activate tyrosine hydroxylase (TH)-synthesizing cells displaying Fos presence; and 3) be modulated by CMS preconditioning.
Brain is a settlement of a number of catecholaminesynthesizing cell groups residing in diff erent brain structures (Dahlstrom and Fuxe 1964; Bjorklund et al. 1973 ) and involved in many physiological and pathological processes (Hui et al. 2003; Kvetnansky et al. 2009) .
Th e dopaminergic SN is a structure located in the midbrain playing an important role in the eye movement, motor planning (Parkinson's disease is characterized by the death of dopaminergic neurons in the substantia nigra), reward-seeking, learning, addiction, etc. (Burns et al. 1983; Chinta and Andersen 2005; Groger et al. 2014) . Actually, SN consists of three diff erent parts, pars compacta, pars reticulata, and pars lateralis (Dahlstrom and Fuxe 1964) . Th e SNC serves mainly as an input to the basal ganglia circuit, supplying the striatum with dopamine, while the SNR serves mainly as an output, conveying signals from the basal ganglia to many other brain areas (Lee and Tepper 2009) . Th e SNL is made up of diff erent neuronal populations: one projecting to the inferior colliculus and another directed to the striatum and amygdala (Moriizumi et al. 1992) .
Th e dopaminergic VTA, located in the bottom of the midbrain just above the interpeduncular nucleus, is origin of the frontal mesocortical dopaminergic system projecting to certain cortical and mesolimbic terminal fi elds, including the nucleus accumbens and olfactory tubercles, implicated in reward, pleasure, and addictive behavior (Yun et al. 2004; Ranaldi 2014; MacInnes et al. 2016) . Th e term VTA is oft en used as a synonym for A10 dopaminergic cell group.
Th e noradrenergic LC is situated in the dorsal pontine tegmentum on the lateral sides of the fourth ventricle. It is the major noradrenergic nucleus of the brain (Berridge and Waterhouse 2003) innervating via the dorsal noradrenergic bundle many brain areas involved in the control of diff erent physiological functions, including the regulation of arousal, the autonomic function infl uencing the sympathetic and parasympathetic activities, wakefulness, stress response, anxiety, and depression (Samuels and Szabadi 2008) .
Th e noradrenergic sLC spreads ventrally to LC (Westlund and Coulter 1980) . Th e sLC neurons are directed to the sympathetic preganglionic neurons of the intermediolateral cell column of the thoracic cord. Th e sLC neurons also heavily project to the cranial somatic nerve nuclei (Westlund and Coulter 1980) , involved in physiological responses to stress and panic.
Th e pontine A5 noradrenergic cell group is strongly involved in the brain control of the cardiovascular function (Woodruff et al. 1986 ) and displays a clear central respiratory modulation (Guyenet et al. 1993) .
Th e dorsomedial A2 medullary noradrenergic neurons are widespread in the NTS, i.e. in the major sensory nucleus in the dorsal medulla, receive cardiovascular, visceral, respiratory, gustatory, and orotactile signals (Chan et al. 1995; Williams et al. 2000) . Th e adjacent area postrema (AP), a chemoreceptor trigger zone, is one of the so-called circumventricular organs located on the dorsal inferior surface of the medulla oblongata at the caudal end of the fourth ventricle (Bessing et al. 1987; Horsburgh and Massoud 2013) . Th e blood has direct access to AP neurons because its location outside of the blood-brain barrier and thus receives inputs from blood-borne drugs or hormones. It is considered to be an integrative area for various toxic signals preventing of intoxication (Ossenkopp and Eckel 1995) .
Th e caudal ventrolateral A1 medullary noradrenergic neurons are responding to variety of visceral, somatic, and supramedullary inputs in a manner that closely mimics the eff ects of these inputs on the peripheral sympathetic vasomotor outfl ow (Guyenet et al. 1996) . Th e data of antipsychotic studies regarding the catecholamines involvement are extensive. It has been shown that the eff ects of the antipsychotic drugs on catecholamines may be dose-or sort-dependent. Differences in the eff ect of the haloperidol, clozapine, olanzapine, risperidone, and ziprasidone on the extracellular levels of dopamine and noradrenaline in the medial prefrontal cortex and dopamine in the striatum have been demonstrated (Westerink et al. 2001) . Conversely, noradrenaline reuptake inhibition has been shown to augment the effi cacy of the classical D2-antagonists in the treatment of schizophrenia (Linner et al. 2002) . Th e DA metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) levels have been shown to be selectively increased in the VTA-A10 but not A9 region cell bodies by foot shock and conditioned stress paradigm indicating that the cell bodies of the mesocortical dopaminergic system origin are activated by stress in contrast to dopamine neurons innervating the striatum (Deutch et al. 1985) .
Fos protein expression has generally been used as a cell activity marker (Dragunow and Faull 1989) . In the SNC, Fos expression increase has been demonstrated aft er 60 min of sleep deprivation induced by gentle handling, suggesting that dopaminergic nigral activation may be triggered by sleep deprivation (SD) earlier than motor responsiveness (Santos et al. 2008 ). It has also been shown that the modulation of target gene expression by Fos may infl uence the addictive behavioral responses to opiates (Bontempi and Sharp 1997) . Expression of Fos in transmitters-characterized neurons aft er stress (corticotropin-releasing factor/ catecholamine neurons/paraventricular nucleus/medulla oblongata/colchicine) has also been monitored (Ceccatelli et al. 1989) . It has been demonstrated that TH neurons in the NTS may be activated during different states of arousal (Asmus and Newman 1994) .
Th e objective of the present study was to investigate the Fos protein expression in the catecholamine-synthesizing neurons in selected brain areas including the substantia nigra, the ventral tegmental area, the locus coeruleus and subcoeruleus, the ventrolateral pons, the nucleus of the solitary tract, area postrema, and the ventrolateral and dorsomedial medulla, in non-stressed and mild stress preconditioned animals aft er one-shot ASE administration. Th e aim of the study was to reveal whether acute ASE treatment may 1) activate Fos expression in the catecholaminergic areas selected; 2) activate tyrosine hydroxylase (TH)-synthesizing cells indicated by Fos protein presence; and 3) be modulated by CMS preconditioning. In this study, single and double light and fl uorescence microscopic immunohistochemistry was employed and the data quantitatively evaluated 90 min aft er ASE administration.
Materials and Methods
Animals. Adult male Wistar rats (n=28, Charles River, Germany) weighing 220-250 g were used. Th ey were housed two per cage in a room with controlled temperature (22±1 °C), light (12-hour light/dark cycle with lights on at 06:00 a.m.), and humidity (55±10%). Animals were provided with a regular rat chow (dry pellets) and tap water ad libitum. Principles of the laboratory animal care and the experimental procedures used were approved by Animal Care Committee of the Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Slovak Republic. Th e investigation was carried out in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 80-23) revised 1996 guidelines for the Care and Use of Laboratory Animals published by the U.S. National Institutes of Health. An eff ort was made to minimize the number and suff ering of animals.
Experimental design. Th e rats were divided into 4 groups: control (vehicle, CON, n=6), asenapine (ASE, n=6), CMS + vehicle (CMS, n=8), and CMS + asenapine (CMS+ASE, n=8) . Th e CMS consisted of a combination of diff erent mild stressors (Majercikova et al. 2014; Kiss 2015, 2016) , including: restraint (RE, animals were placed into plastic restrainers), social isolation (SI, animals were kept individually in cages), crowding (CR, animals from two cages were placed into one cage), cold (CO, animals with cages were placed into a cold room at 4 °C), and swimming (SW, animals were put into 45 cm high × 25 cm wide glass cylinders, fi lled with normal 25±1 °C water up to 36 cm of the height). Th e animals received one stress challenge per day in the following sequence and duration of exposure: RE ( . In order to minimize the stressors predictability and avoiding the animals to adapt to the stress stimulus, the particular stressor was applied each day at diff erent time.
Th e CMS and CMS+ASE animals were exposed to the stressor for 21 days. On the 22 nd day, ASE and CMS+ASE treated groups of rats were injected subcutaneously (s.c.) with ASE (0.3 mg/kg of b.w. dissolved in saline (Sigma St. Louis MO, A7861) and CON and CMS ones with saline (s.c., 300 μl/rat), respectively.
Fos/TH immunohistochemistry. Th e animals were sacrifi ced by a transcardial perfusion with fi xative under sodium pentobarbital (50 mg/kg, i.p., Spofa, Czech Republic) anesthesia 90 min aft er the saline or ASE injection. Th e perfusion was performed via the aortic arch with 50 ml of cold isotonic saline containing 450 μl of heparin (5000 IU/l, Zentiva, Slovakia) followed by 250 ml of fi xative containing 4% paraformaldehyde (Sigma-Aldrich, Germany) in 0.1 M phosphate buff er (PB, pH 7.4). Th e brains were removed from the skulls, postfi xed in a fresh fi xative overnight, washed in 0.1 M PB at 4 °C overnight, and infi ltrated with 30% sucrose (Slavus, Slovakia) for 48 h. Four series of coronal sections of 30 μm thickness were cut on a cryocut (Hyrax c-50). Th ey were repeatedly washed in cold 0.1 M PB and preincubated with 0.3% H 2 O 2 (Sigma-Aldrich, Germany) in 0.1 M PB for 15 min at room temperature (RT). Th ereaft er, the sections were rinsed 3×10 min in 0.1 M PB and incubated with a rabbit anti-Fos polyclonal antibody (1:3000) in 0.1 M PB containing 4% normal goat serum (Gibco, Grand Island, NY, USA), 0.3% Triton X-100 (Sigma-Aldrich, Germany), and 0.1% sodium azide (Sigma-Aldrich, Germany) for 48 h at 4 °C.
Fos staining was visualized by two diff erent ways: a) One set of Fos sections containing SN and VTA, aft er several rinsing in PB, was incubated with biotinylated goat anti-rabbit IgG (1:500) in PB for 90 min at RT. Next PB rinsing was followed by incubation with the avidin-biotin peroxidase complex (1:250) for 90 min at RT. Aft er several washings in 0.05 M sodium acetate buff er (SAB, pH 6.0), Fos-antigenic sites were visualized by 3,3´-diaminobenzidine tetrahydrochloride (0.0625% DAB enhanced with 2.5% nickel chloride, Sigma-Aldrich, Germany), in SAB containing 0.0006% H 2 O 2 . Developing time was 6-8 min. Th e heavy metal-intensifi cation of DAB yielded to black staining in the Fos-labeled nuclei.
b) Another set of Fos sections containing LC, sLC, PON-A5 NTS-A2, AP, and VLM-A1, aft er several rinsing in PB, was incubated with the goat anti-rabbit IgG labeled with Alexa Fluor555 (1:250) overnight at RT.
Th e colocalization of Fos with TH was performed in both Fos-staining procedures by incubation of the Fos-labeled sections with the chicken anti-tyrosine hydroxylase polyclonal antibody (TH, 1:2000) labeled either with Alexa Fluor 555 labeled goat anti-chicken IgG (1:250) (a -section processing) or Alexa Fluor 488 labeled goat anti-chicken IgG (1:250) (b -section processing), both overnight at RT. Finally, the tissue sections were mounted in semi-darkness onto slides, left to dry in RT, coverslipped with Pertex (Stockholm, Sweden), and stored in dark histological boxes.
Th e brain structures studied. Th e location of the brain structures studied, including the substantia nigra pars compacta, reticularis, and lateralis, the ventral tegmental area, the locus coeruleus and subcoeruleus, the central gray tegmental nucleus, pons, the nucleus of the solitary tract, the area postrema, and the ventrolateral medulla, was identifi ed based on the rat brain atlas (Paxinos and Watson 2007) with coordinates for SN and VTA = bregma -5.60-6.04 mm; LC, sLC, PON-A5 = bregma -9.68-10.04 mm; and NTS, AP, VLM-A1 = bregma -13.68-14.08). Th e single Fos profi les counting was performed unilaterally (in Adobe Photoshop 7.0 program) from photomicrographs captured from 5-6 representative sections/structure in an Axio-Imager A1 light microscope (Carl Zeiss, Jena) coupled to a video camera and monitor. An average count per section was determined for each animal. Th e identifi cation of Fos/TH colocalizations was performed on photomicrographs captured on the above-mentioned microscope, using double fl uorescent or synchronized fl uorescent and transmission illuminations, as described previously (Majercikova et al. 2012) . Parallel fl uorescent and transmission illumination, the transmission light served to adjust the correct ratio between the intensity of the two beams to reach final picture clearly revealing Fos-immunolabeled nuclei within the fl uorescent perikarya. Actually, the Fos/TH colocalization was expressed in percentage, whereas the percentage represents the ratio between the total Fos-labeled vs. Fos/TH colocalized perikarya.
Antibodies. Th e primary rabbit anti-Fos antibody is a gift from Dr. J.D. Mikkelsen (Denmark). Th e chicken anti-TH polyclonal antibody (ab76442), the secondary goat anti-chicken antibody (ab150114), Alexa Fluor 555 labeled goat anti-rabbit IgG (ab150078), and Alexa Fluor 488 labeled goat anti-chicken IgG (ab150169) were purchased from Abcam (Cambridge, UK). Th e Avidin-biotin-peroxidase complex (ABC, PK-6101, VectorStain Elite ABC Kit) was obtained from Vector Lab. (Burlingame, CA, USA).
Statistical analysis. Statistical quantifi cation of Fos expression was carried out by two-way analysis of Figure 1 . Distribution of TH-immunoreactive perikarya and projections in the ventral midbrain within the SNC, SNR, SNL, and VTA (A). Picture (B) demonstrates Fos profi les density and their distribution in SNL, which is representative for all four groups of animals and for all experimental conditions. Abbreviations: IP -interpeduncular nucleus, SNC -substantia nigra pars compacta SNR -substantia nigra pars reticulata, SNLsubstantia nigra pars lateralis, VTA -ventral tegmental area C, E) demonstrate the characteristic shape of the individual catecholamine cell group visualized by TH immunostaining and on the right side the response of these structures to ASE treatment. As seen, the ASE administration induced only a negligible Fos-expression (white stars) within all the three structures presented (B, D, F). Abbreviations: LClocus coeruleus, sLC -locus subcoeruleus, A5 (PON-A5) -ventrolateral pons variance (ANOVA) followed by Tukey's post hoc test. Statistical evaluation was performed by SIGMASTAT soft ware for windows (StatSoft ). All the data were expressed as mean ± SEM. Th e value of p<0.05 was considered as statistically signifi cant.
Results
Systematic mapping of the Fos protein expression was performed on the serial coronal sections, containing the selected brain catecholamine-synthesizing structures, including SNC, SNR, SNL, LC, sLC, PON-A5, NTS-A2, AP, and VLM-A1 in four groups of animals (CON, ASE, CMS, and CMS+ASE) that underwent 21 days-lasting mild stress preconditioning.
Between the individual groups of animals and brain structures investigated diff erent amount of Fos expression occurred. Generally, in the CON and CMS groups of animals, none or only a negligible number of neurons displayed Fos expression in the catecholamine-synthesizing neurons including the SNC, SNR, and VTA, except the SNL, where regularly numerous Fos-labeled elements (25-50/section) occurred ( Figures 1A, 1B ) Th e Fos profi les were evenly distributed over the whole SNL area situated in the SNR upper margin ( Figure 1B ). On the other hand, no Fos expression was seen in the rest of the catecholamine-synthesizing structures investigated including LC, sLC, PON-A5 (Figure 2) , AP, NTS-A2, and VLM-A1 (Figure 3) . Fos response to ASE treatment. Ninety minutes aft er ASE treatment, very clear Fos response was ob-served only in the SNC, SNR, and VTA in ASE-and CMS+ASE-treated groups (Figure 4) . No Fos presence was observable in ASE or CMS+ASE groups in the other catecholamine-containing structures, including LC, sLC, NTS-A2, PON-A5, AP, and VLM-A1 (Figures 2, 3) . Although LC neurons did not show any Fos presence, a small number of Fos-immunoreactive cell nuclei emerged in some of the adjacent central gray tegmental nuclei (not shown).
As mentioned above, distinct Fos expression was detected in the SNC, SNR, and VTA in the ASE and CMS+ASE groups of rats. Generally, Fos expression was densely-packed in the SNC and more dispersed in the SNR. In the majority ASE-and CMS+ASE-treated animals, main accumulation of Fos profi les occurred in the ventral portion of the SNC and SNR ( Figure 4A ). Likewise, in the SNC and SNR, the Fos profi les in the VTA were also accumulated mainly in its ventral portion adjacent to the interpeduncular nucleus ( Figure 4B) .
Th e CMS preconditioning did not aff ect the Fos expression in the SNL and did not signifi cantly altered the Fos expression in the SNC, SNR, and VTA ( Figure 5 ).
Fos/TH colocalizations. TH-immunostaining performed on the serial coronal sections revealed a large number of TH-immunolabeled cell bodies in all the brain catecholamine-containing structures selected. Most densely packed groups of TH-labeled perikarya were observed in the VTA, SNC ( Figure  1A ), and LC (Figure 2A ). Less densely packed TH-labeled perikarya were seen in the SNR, SNL, sLC and PON-A5 ( Figures 2B, 2C) , NTS-A2, AP, and VLM-A1 ( Figures 3A, 3B, 3C ). However, Fos/TH colocaliza- tions, visualized either by combination of two fl uorescent dyes or combination of a fl uorescent dye (TH) with the nickel intensifi ed DAB staining (Fos), were observed only in the ASE and CMS+ASE groups of animals in the SNC, SNR, and VTA. Th e most extensive Fos/TH colocalizations occurred in the ventral SNC, followed by the VTA and the SNR (Figure 6 ). In concordance with the Fos appearance, the Fos/TH colocalizations were also observable mainly in the ventral portions of the SNC, SNR, and VTA ( Figure 6 ). , and VTA (C) in animal groups treated with ASE (the pictures are representative for both the ASE and CMS+ASE groups of rats). Th e colocalized Fos is labeled by red and free Fos by blue color. Th e picture was made by merging an identical TH-fl uorescent and Fos-DAB-nickel stained sections and the Fos-labeled particles artifi cially colored in the Adobe Photoshop (7.0) channel mixer and hue/saturation programs.
Th e CMS preconditioning did not alter the number of Fos/TH-coexpressing neurons in the SNC, SNR, and VTA in CMS+ASE group of animals ( Figure 7 ).
Discussion
Th e data of the present study showed that saline or CMS alone did promote only a negligible Fos expression in the brain catechomaninergic structures studied. On the other hand, ASE treatment elicited Fosexpression, however, only in the SN and the VTA. CMS preconditioning did not alter the Fos response to ASE in the SNC, SNR, and VTA. Except the central gray tegmental nuclei adjacent to LC, where a small number of Fos profi les was detectable, no Fos presence was observed in the rest of the structures investigated including LC, sLC, NTS-A2, PON-A5, AP, and VLM-A1. In the SNC, SNR, and VTA of ASE and CMS+ASE groups, increased Fos/TH colocalizations from 10 to 45% occurred. Th e amount of Fos/TH colocalizations was not infl uenced by CMS preconditioning.
Catecholamine-synthesizing neurons are located in specifi c and anatomically well-defi ned brain structures, as revealed by immunohistochemical studies (Dahlstrom and Fuxe 1964; Bjorklund and Nobin 1973; Swanson and Hartman 1975; Hokfelt et al. 1976; Lindvall and Bjorkland 1983) . It has been shown that they are involved in a number of brain functions (Kobayashi 2001; Pacak and Palkovits 2001; Kvetnansky et al. 2009) . Th e central noradrenergic pathways activation by atypical antipsychotics has been believed to play a positive role in the treating the negative symptoms and cognitive impairment of schizophrenia (Dawe et al. 2001) . Using immunohistochemistry, Fos expression in the LC and sLC, but not PON-A5 area, has been induced by acute olanzapine and clozapine treatments (Dawe et al. 2001) . LC is the major brain noradrenergic nucleus, infl uencing the activity of the entire brain via dorsal and ventral bundles of axons (Ungerstedt 1971) . LC has long been thought to be involved in states of cognitive processes. Th ese functional characteristics make this nucleus interesting with respect to the signs of schizophrenia, especially the disease negative symptoms (Nilsson et al. 2005) . Ohashi et al. (2000) have even shown that clozapine and olanzapine administrations induce not only Fos expression in the LC but also noradrenaline release by stimulating noradrenergic neuronal activity in the LC, which leads to a consequent, increase of the noradrenaline induced Fos expression in the mPFC via β-adrenergic receptors. In the present study, the acute ASE treatment failed to induce Fos expression in the LC and sLC. In addition, no Fos expresion response to ASE was found in several other brain stem structures containing catecholamine-containing cells including the PON-A5, NTS-A2, AP, and VLM-A1 areas.
It is interesting to note that except the SN and VTA, none of the other structures studied was aff ected by ASE treatment. Th or and Helke (1988) have demonstrated that most of the VTA groups of projecting neurons are considerably intermixed with the exception of those that project to the lateral septum, the lateral habenula, and the hippocampal formation, which are concentrated in the ventral and medial parts of the VTA. In the present study, the most pronounced eff ect of ASE treatment on the Fos expression was detectable mainly in the ventral parts of both SN and VTA, which may off er a suggestion that ASE might activate certain group of neurons that project to the lateral septum, lateral habenula, and hippocampus. Indeed, previously we have demonstrated a strong stimulatory eff ect of a single ASE treatment on the septal neurons located in its ventral-lateral portion (Majercikova et al. 2014) . Inhibition of the central dopamine functions is an important property of antipsychotic drugs, whereas the mesolimbic and nigrostriatal portions of the dopaminergic system are the main targets for the mental and extrapyramidal actions, respectively. Furthermore, it has been shown that injection of the D2 receptor antagonists, haloperidol and metoclopramide, in rats resulted in a dose-dependent induction of Fos-like-immunoreactivity in the medial portion of the SNR. However, the above-mentioned SNR staining occurred exclusively in neurons, which were not immunoreactive for TH and could be antagonized by pretreatment with the anticholinergic drug scopolamine (Wirtshaft er and Asin 1995). In the present study, many TH cells were activated by the ASE not only in the SNC and VTA but also in the SNR portion, i.e. area similarly localized to that mentioned above. Actually, the phenotype character of the other populations of the activated SNR neurons, represented by only the presence of Fos-immunolabeled nuclei, was not identifi ed in the present study.
Th ere is no doubt that Fos expression detection is one of the most commonly used indicators of an increased cell activity in the brain induced by a number of various stimuli including stress paradigms, whereas, generally, the neuronal activation mediated by Fos levels can be detected within 0.5 h with the peak in 1-2 h (Morgan and Curran 1991) . Diff erent response to stressors has been shown in the mesencephalon dopaminergic cells in the case of the footshock and the conditioned stress paradigm. Both these stress conditions selectively aff ected the DOPAC levels by increasing them in the A10 cell area (VTA) but not in the A9 (SNR) region (Deutch et al. 1985) . Th ese data demonstrate that the cell bodies of the mesocortical dopaminergic system origin are activated by stress in contrast to DA neurons innervating the striatum, indicating that the mesocortical dopaminergic neurons exhibit diff erent regulatory features than mesolimbic or nigrostriatal neurons (Deutch et al. 1985) . Similarly, selective increases in Fos protein expression in response to stressor has been reported in the ventral mesencephalon, where restraint stress for 30 min increased the number of DA neurons exhibiting Foslike immunoreactivity in the ventral tegmental area (VTA), but not in the substantia nigra or retrorubral fi eld (Deutch et al. 1991) In the present study, however, the 21 days lasting CMS preconditioning alone had no signifi cant eff ect on the Fos expression in the SNC, SNR, and VTA, which might be explained by the possible adaptation of animals to the daily repeated mild disturbances, since increased Fos expression has been reported in the SNC of adult male C57/BL6J mice aft er a gentle handling used for the introducing of a sleep deprivation (Santos et al. 2008) .
On the other hand, in the present study, ASE had a strong eff ect on the Fos expression in the SNC, SNR, and VTA, which was not aff ected by the CMS. However, previously we have shown that CMS may alter the ASE-induced Fos expression in the Meynert's nucleus (Majercikova and Kiss 2016) , which support the notion that diff erent brain structures may have a diff erent sensitivity to the same stressor. ASE treatment also induced a number of Fos/TH colocalizations in the SNC, SNR, and VTA localized mainly in the ventral positions of the mentioned structures. Th e exposure of female California mice to three episodes of defeat, but not a single one, induced also more Fos/ TH-positive cells in the ventral than the dorsal VTA indicating that VTA dopamine neurons in particular are more sensitive to aversive contexts compared with controls (Greenberg et al. 2015) . It has also been demonstrated by activation of Fos expression that repeated social stress episodes induce a long-lasting neural change that may lead to an augmented functional activation in the VTA neurons, however the authors did not mention whether this activation also concerned the TH population of neurons.
In summary, the present data indicate that ASE does not have ubiquitous eff ect over the brain catecholaminergic structures, but its action is mainly oriented to the SN and VTA partially aff ecting the THsynthesizing neurons. In these structures, the ASE stimulatory eff ect is not altered by the CMS preconditioning. Th us, the present study provides a new anatomical/functional knowledge about the nature of the acute ASE treatment on the activity of certain groups of the brain catecholamine-synthesizing neurons and its missing interplay with the CMS preconditioning.
